Freshworks Chennai Marathon’ powered by Chennai Runners launches official T Shirt and medals

Chennai, December 302023:

The Chennai Runners, a not-for-profit organization run by passionate runner-volunteers since 2006, and Freshworks Inc. (NASDAQ: FRSH), the global software as a service company from Chennai, today launched the official T-Shirt, medals for the participants and an event  magazine, called Run Down in the city today. Thiru Shankar Jiwal, DGP Tamilnadu, launched the official T-Shirt. Mr. Radhakrishnan, Additional Chief Secretary and Commissioner of the Greater Chennai Corporationlaunched the medals and Mr. Mohan Venkatesan, Sr Vice President and Head Tamil Nadu, Sundaram Finance Ltdlaunched the magazine. Present at the occasion were Mr. V P Senthilkumar, Race Director and Dr.  Lakshmi Sundar, President, Chennai Runners. 

This year the 12th edition of the Freshworks Chennai Marathon 2024, powered by Chennai Runners will be held on Saturday, 6th January 2024 and is certified by AIMS (The Association of International Marathons and Distance Races), a worldwide association of the organizers of long-distance road running races. Chennai Marathon 2024 is recognized by Abbott World Marathon Majors as a qualifier event.

Freshworks Chennai Marathon 2024, powered by Chennai Runners, the largest running event in Chennai and the second-largest marathon in India, will comprise four events for men and women including, a Full Marathon (42.195 Km) – the flagship race of the event, the Perfect 20 Miler (32.186 Km), the Half Marathon (21.097 Km) and the 10 Km Run.

This year the Freshworks Chennai Marathon will see the participation of over 35% women runners. The marathon will have participation from visual impaired runners, blade runners, and wheelchair runners. Like the previous edition, this year the Freshworks Chennai Marathon 2024 powered by Chennai Runners seeks to increase awareness of Type 1 diabetics and intends to raise funds for people with insulin needs thereby supporting monthly needs of Rs.12,000-18,000/- towards their insulin expenses.

About Author